Principal consultant

General Management, Fund Raising, Strategy, and Corporate Development

Headed business development. Lead strategic planning process. Overhaul IVD regulatory capabilities. Collaborate and gain credibility with challenging R&D organization. Augmented product marketing and development. Steered various quality functions.

Evaluated and implemented strategic options for the company, after assessing and revising business strat-egy. Secured bridge financing and managed day-to-day cash flow. Selected and managed investment bank-ing relationships for sale of all or part of company. Further developed product line.

Led business development, including collaborations, licensing, investments and acquisitions. Managed research and novel biomarker strategy, including research assay development, protein science, molecular diagnostics, and nanochemistry.

Established first strategic marketing group. Built group of international product directors across a number of medical of specialties – cardiology, neurology, intensive care, nephrology, emergency medicine, and oncology. Managed new instrument development. Augmented existing market development and product management abilities. Filled significant gaps in the company’s strategic marketing approach, adding de novo forecasting, market research, market segmentation, positioning, and statistics.

Built up the firm’s healthcare research franchise and expertise. Identified high-quality, growth stock and emerging growth investments out of existing public equities and private firms. Extended industry expertise and relationships across other firm activities, including venture capital. Marketed selected investment ide-as, including IPOs and secondary offerings, to external institutional investors, as well as internal portfolio managers and high-net-worth, private brokers.